IL17A and chronic mucocutaneous candidiasis: Further, patients suffering from chronic mucocutaneous candidiasis exhibit defective IFN-I responses and suppressed antifungal IL-17 immunity (Casanova et al., 2012, Liu et al., 2011, Smeekens et al., 2013, van de Veerdonk et al., 2011).